(American Society for Biochemistry and Molecular Biology) Glycans on antibody drugs can significantly affect their safety and efficacy. A study conducted by NIST investigates how well pharmaceutical and research labs are equipped to measure this important post-translational modification.

Original source: https://www.eurekalert.org/pub_releases/2020-01/asfb-ttm010220.php